Long Covid Newsletter
Issue #30March 30, 20267 studies

Long COVID antibodies from patients cause pain symptoms when injected into mice

This week brought some of the most compelling evidence yet for what might be driving long COVID symptoms—and it comes from an unexpected source: mice that received antibodies from long COVID patients.

🐭 Long COVID antibodies trigger pain in mice

  • Researchers injected antibodies (IgG) from long COVID patients into healthy mice and observed pronounced mechanical hypersensitivity—the mice became much more sensitive to touch and pressure

  • The effect was persistent and could be reproduced even with antibodies collected 2 years later from the same patients who remained symptomatic

  • Proteome-wide analysis identified elevated autoantibodies that were specific to different patient subgroups and remained stable over time

Why it matters: This provides direct experimental evidence that autoantibodies in long COVID patients may actually cause symptoms rather than just correlate with them—potentially opening new therapeutic targets.

🥈 Top 2% journal 🔗 Cell reports. Medicine Journal Article 🗓️ Mar 25

Key Findings

🧬 MicroRNA changes reveal inflammatory patterns in long COVID women

  • Analysis of blood cells from adult women with long COVID revealed 37 differentially expressed microRNAs (10 upregulated, 27 downregulated)

  • 28 of these microRNAs had been previously linked to inflammation or COVID-19, consistent with long COVID's association with persistent inflammatory states

  • Three specific microRNAs (hsa-miR-1307-3p, hsa-miR-26a-5p, and miR-186-5p) were validated as potential biomarkers for the condition

💡 These molecular signatures could help develop blood tests to diagnose long COVID and monitor treatment responses.
🔗 Anais da Academia Brasileira de Ciencias Journal Article 🗓️ Mar 25

💊 Paxlovid shows mixed effects on preventing long COVID

  • Analysis of 19,413 patients found Paxlovid reduced gastrointestinal long COVID symptoms by 37% but nearly doubled the risk of eye and ear-related symptoms (97.4% increase)

  • In patients aged 65-75 who weren't hospitalized, Paxlovid was associated with a 16.8% reduction in overall long COVID risk

  • No statistically significant effects were observed for other organ-specific outcomes across all age groups

💡 The antiviral's organ-specific effects suggest long COVID may involve different mechanisms in different body systems.
🥉 Top 5% journal 🔗 Communications medicine Journal Article 🗓️ Mar 25

🧠 Processing speed problems underlie long COVID memory issues

  • Study of 61 participants found that COVID-19 survivors showed impaired processing speed and cognitive control, with greater severity in hospitalized patients

  • These processing deficits directly led to slowed learning and problems during memory encoding stages

  • The cognitive slowing affected episodic-semantic memory tasks due to increased interference during memory formation

💡 Understanding that memory problems stem from processing speed issues could guide more targeted cognitive rehabilitation approaches.
Top 50% journal 🔗 Applied neuropsychology. Adult Journal Article 🗓️ Mar 24

🩸 Routine blood tests may reveal long COVID biomarkers

  • Among 2,792 COVID-19 patients followed up, 182 (6.52%) developed long COVID with symptoms including fatigue, cough, and insomnia

  • Long COVID patients showed higher red blood cell counts but lower hemoglobin-related indices and platelet counts compared to recovered patients

  • Risk factors included older age and more severe acute symptoms during initial infection

💡 Standard blood work could potentially help identify long COVID patients without needing specialized tests.
Top 20% journal 🔗 Frontiers in public health Journal Article 🗓️ Mar 26

🧘 Online Qigong and acupressure help some long COVID patients

  • 12 participants in an 8-week telemedical program reported increased calmness, improved breathing, and symptom relief

  • The online format helped integrate practices into daily routines, though cognitive impairments and fluctuating fatigue created barriers

  • Some participants experienced discomfort with acupressure, and results were mixed with some reporting minimal benefits

💡 Self-care approaches delivered remotely may provide structure and emotional regulation for long COVID patients, though individual responses vary.
Top 20% journal 🔗 Complementary therapies in medicine Journal Article 🗓️ Mar 25

🔬 NK immune cells show dysfunction in long COVID patients

  • Long COVID patients had significantly depleted CD56+CD16+ NK cells and altered T-cell activation compared to healthy controls and recovered patients

  • Single-cell analysis revealed broad gene expression changes affecting circadian rhythms, neurotransmitter pathways, and inflammatory responses

  • Functional tests confirmed that NK cells from long COVID patients had reduced inflammatory capacity

💡 The immune system's natural killer cells appear to be both depleted and dysfunctional in long COVID, potentially explaining persistent symptoms.
🥉 Top 5% journal 🔗 Frontiers in immunology Journal Article 🗓️ Mar 25

Implications

This week's research points toward long COVID as a complex autoimmune and inflammatory condition involving multiple body systems. The mouse antibody study provides the strongest evidence yet that patient antibodies can directly cause symptoms, while the other findings reveal measurable changes in immune cells, blood markers, and brain processing that could lead to better diagnostic tools and targeted treatments.

Studies in this issue

Primary sources used for this newsletter.

  1. Antibodies from long COVID patients cause symptoms when given to mice
    main storyCell reports. Medicine2026-03-25PMID 41881023
  2. Changes in small RNA levels in blood immune cells of women with Long COVID
    key findingAnais da Academia Brasileira de Ciencias2026-03-25PMID 41880397
  3. Remote Acupressure and Qigong for Fatigue After COVID-19: A Qualitative Study
    key findingComplementary therapies in medicine2026-03-25PMID 41881283
  4. Slower thinking and reduced self-control linked to memory problems in people recovered from COVID-19
    key findingApplied neuropsychology. Adult2026-03-24PMID 41873548
  5. Paxlovid’s effects on long COVID risk vary by organ and age
    key findingCommunications medicine2026-03-25PMID 41876769
  6. Long COVID symptoms and risk factors in 2,792 people after COVID-19 infection
    key findingFrontiers in public health2026-03-26PMID 41883830
  7. Changes in natural killer cell genes are linked to lasting symptoms of long COVID
    key findingFrontiers in immunology2026-03-25PMID 41878441

Continue reading

All Long Covid issues